Cerity Partners
VYNT

Cerity Partners’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Cerity Partners’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-23,907
Closed -$171K – 1253
2022
Q1 		$171K Hold
23,907
– – ﹤0.01% 873
2021
Q4 		$161K Hold
23,907
– – ﹤0.01% 950
2021
Q3 		$279K Hold
23,907
– – 0.01% 578
2021
Q2 		$447K Buy
+23,907
New +$446K 0.01% 495

Other funds holding VYNT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JSC
Jackson Square Capital San Francisco, California $719M AUM 144.18% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
CCB
Country Club Bank Kansas City, Missouri $1.69B AUM 16.93% 1-Year Est. Return

Cerity Partners's VYNT Position: Q2 2022 in Review

Cerity Partners sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q2 2022, closing a stake of 23,907 shares — an estimated $171K sold.

Cerity Partners first reported a position in VYNT in Q2 2021 and held it in 4 quarters. The position peaked at $447K in Q2 2021. 21 funds tracked by Wall St. Rank hold VYNT as of Q2 2022.

  • Cerity Partners reported no remaining Vyant Bio, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Cerity Partners sold 23,907 Vyant Bio, Inc. Common Stock shares in Q2 2022, an estimated $171K.
  • Cerity Partners first reported a position in Vyant Bio, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
  • Cerity Partners's Vyant Bio, Inc. Common Stock position peaked at $447K in Q2 2021.
  • 21 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q2 2022.

Based on Cerity Partners's 13F filing for Q2 2022, filed 10 Aug 2022.